Abstract
No public abstract is available from the verified source records.
Polly Niravath, Ivonne Uzair, Hanh Mai, Mailin Li, Jenying Deng, Liliana Guzman, Kelsey Banaglorioso, Rabia Hashmani, Sunil Mathur, Jenny Chang
Abstract
Authors
No local reference links have been materialized yet.
No local citing links have been materialized yet.
A phase II study of docetaxel and pembrolizumab plus interleukin 12 gene therapy in nonmetastatic, anthracycline-refractory triple-negative breast cancer (INTEGRAL)
10.1158/1078-0432.ccr-25-2649 · 2026
No additional external references are available.
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%